#HPV

Topical treatment may be as effective as electrocautery for anal neoplasia but with fewer adverse effects.

LGBTQ disparities exist in cervical cancer prevention—including HPV vaccines—and in rates of anal cancer, notably among those with HIV.

Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.

Human papillomavirus, a common sexually transmitted infection, can cause cervical, anal, and oral cancers.

Vaccines could potentially eliminate cervical, anal, oral and other cancers caused by human papillomavirus.

Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?

Screening for abnormal anal cell changes and treating them early can reduce the risk of progression to anal cancer in people with HIV.

A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.

Dozens of types of HPV can live in the human genital tract, which can increase a women’s risk of acquiring HIV.

A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.

Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.

Women living with HIV in the United States have a greater likelihood of developing cervical cancer than HIV-negative women.